AI assistant
Pfizer Ltd. — Board/Management Information 2023
Nov 16, 2023
60507_rns_2023-11-16_ca02cd99-3013-42f4-913b-18026ad29ca1.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [100 x 41] intentionally omitted <==
Pfizer Limited
The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
November 16, 2023
The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER
Dear Sirs,
Sub: Intimation regarding Appointment of Senior Management Personnel of the Company.
Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby wishes to inform that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has appointed Ms. Aditi Mehta as Category Lead, Vaccines effective December 1, 2023. Accordingly, Ms. Aditi Mehta shall be a Senior Management Personnel effective the said date.
Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A.
Request you to please take the above on record.
Thanking you,
Yours truly, For Pfizer Limited
PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2023.11.16 17:14:54 +05'30' Prajeet Nair
Director – Corporate Services & Company Secretary
Encl: A/a
CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in
Annexure A Additional details of Ms. Aditi Mehta
| Sr. no | Particulars | Details |
|---|---|---|
| 1. | Reasons for change | Fresh Appointment |
| 2. | Date of Appointment and Term | December 1, 2023 |
| 3. | Affirmation as per List/Comp/14/2018- 19 dated June 20, 2018 |
Not Applicable |
| 4. | Relationship inter-se Directors / Key Managerial Personnel / Senior Management Personnel |
Ms. Aditi Mehta is not related to any of the Directors/Key Managerial Personnel / Senior Management Personnel. |
| 5. | Number of Shares held in the Company | Nil |
| 6. | Brief Profile | Ms. Aditi Mehta is a Gold Medalist in Bachelor of Pharmacy from K.M Kundnani College of Pharmacy, Mumbai. Ms. Aditi Mehta is a seasoned pharmaceutical professional with over 13 years of experience in pharmaceutical marketing, strategy & research. Ms. Mehta had a decade long stint with Pfizer Products India Pvt. Ltd., (Pfizer Inc.’s wholly owned subsidiary in India) where she held positions of increasing responsibilities. In her role as Category Lead for Oncology business, she was responsible for the development and execution of the strategy for the Oncology portfolio for India market. Prior to this, Ms. Mehta had a two-year stint with Bristol Myers Squibb as a Business Analyst. Ms. Mehta is proud receipt of various accolades and awards, including the Medico-Marketing Excellence Award 2017 by Pfizer India Country Leadership, Pfizer Global Commercial Award in 2019 for Breast Cancer Access initiatives in India, e4M Health & Wellness Marketing Award 2023 for World Cancer Day Awareness Campaign. Most recently, she has also been selected among the Top 100 Inspiring Women Leaders in Pfizer. |